A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2006
11/15/2006	CN1864434A Wireless microphone communication system
11/15/2006	CN1863811A Stable vitamin B6 derivative
11/15/2006	CN1863800A Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions
11/15/2006	CN1863778A Compounds and methods for treating dyslipidemia
11/15/2006	CN1863543A Dietetic composition
11/15/2006	CN1863527A 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands
11/15/2006	CN1861637A Preparation process of Huai Chinese yam polysaccharose and use thereof
11/15/2006	CN1861626A Metallic salt kind medicine containing glycyrrhizic hypoglycyrrhizic or its derivant and preparation process thereof
11/15/2006	CN1861595A Brugine cyclo hexathio-alcohol kind compound, its preparation process and use
11/15/2006	CN1861581A Preparation of allantoin and allantoin extract from cistanche salsa and their use thereof
11/15/2006	CN1861176A Medicinal composition for treating diabets, and its prepn. method
11/15/2006	CN1861173A Edible cellulose powder used as nutrient therapy medicine for diabetic
11/15/2006	CN1861166A Medicinal composition for treating hyperinsulinar type polycystic overies and its prepn. method
11/15/2006	CN1861152A Health-care medicine for lowering content of cholesterol and triglyceride in blood
11/15/2006	CN1861144A Medicinal decoction for treating yin-blood deficiency type hyperlipidemia and its prepn. method
11/15/2006	CN1861121A Green type medicine bag for reducing weight
11/15/2006	CN1861104A Inula flower extractive used to breat diabets mellitus and hyperlipidemia
11/15/2006	CN1861103A Fatty-acid synthase inhibitor, its prepn. method, and medicine using same as active component
11/15/2006	CN1861099A 蛇油软胶囊 Snake Oil Soft Capsule
11/15/2006	CN1861095A Load type super-fine copper-powder copper-complementary agent, its prepn. method and use
11/15/2006	CN1861094A Load type super-fine zinc powder zinc-complementary agent, its prepn. method and use
11/15/2006	CN1861093A Load type super-fine iron powder iron-complementary agent, its prepn. method and use
11/15/2006	CN1861091A Load type molecular iodine complementary agent, and its prepn. method and use
11/15/2006	CN1861090A Toxicity-expelling fibrous nutrient and its prepn. method
11/15/2006	CN1861077A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/15/2006	CN1861069A Use of tanshinone type compounds for preparing medicines to treat high blood-fat disease
11/15/2006	CN1860900A Tea with peony flower, and its prepn. method
11/15/2006	CN1860898A Fat-control tea
11/15/2006	CN1284851C Somatic cell derived embryonic stem cell and its differentiated cell
11/15/2006	CN1284793C C-aryl glucoside sglt2 inhibitors
11/15/2006	CN1284574C Medication for reducing blood fat and preparation method
11/15/2006	CN1284572C Preparation from natural products for nourishing the liver and preparing method
11/15/2006	CN1284570C Chinese traditional medicine for treating hyperlipemia and preparation method thereof
11/15/2006	CN1284544C Application of Hibiscus sabdariffa Linn extractive in preparing medicine for inhibiting cardiac and cerebral vascular diseases
11/15/2006	CN1284522C Dextrose and insulin fluid formulation for intravenous infusion
11/15/2006	CN1284487C Beverage capable of lowering and preventing high blood sugar
11/14/2006	US7135586 Biphenylcarboxamides useful as lipid lowering agents
11/14/2006	US7135491 5-Aryltetrazole compounds and uses thereof
11/14/2006	US7135490 Method for the treatment of glomerulonephritis
11/14/2006	US7135488 Pyrrolyl-thiazole derivatives
11/14/2006	US7135486 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
11/14/2006	US7135475 Antidiabetic agents
11/14/2006	US7135471 Aryl oximes
11/14/2006	US7135321 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents
11/14/2006	US7135286 Pharmaceutical and diagnostic business systems and methods
11/14/2006	US7135279 4-alpha glucotransferases; enzymes inhibitors; enantimorphs; adrenergic blocking agents; proteases; superoxide dismutases; carbonic anhydrases
11/14/2006	CA2399842C Microfabricated devices for the storage and selective exposure of chemicals and devices
11/14/2006	CA2379572C Polymorphic salt
11/14/2006	CA2342271C Gem substituted hydroxamic acids
11/14/2006	CA2228049C Two-phase preparation
11/14/2006	CA2214072C Benzo [b] thiophene compounds, intermediates, processes, compositions, and methods
11/09/2006	WO2006119038A1 Compositions and methods for controlling glucose uptake
11/09/2006	WO2006118341A1 Novel lactam compound
11/09/2006	WO2006118328A1 Degranulation inhibitor
11/09/2006	WO2006118320A1 Thienopyrimidone compound
11/09/2006	WO2006118316A1 Inhibitor for lipid accumulation in liver
11/09/2006	WO2006118314A1 Agent for suppressing accumulation of lipid in liver
11/09/2006	WO2006118313A1 Novel polypeptide and use thereof
11/09/2006	WO2006118307A1 Therapeutic agent for pain
11/09/2006	WO2006118256A1 2-aminoquinazoline derivatives
11/09/2006	WO2006118246A1 Transdermal absorption accelerator
11/09/2006	WO2006118196A1 Dpp4 inhibitor and pharmaceutical application thereof
11/09/2006	WO2006118137A1 Granular preparation containing biguanide compound
11/09/2006	WO2006118131A1 Peptide having anti-anxiety effect and method for screening thereof
11/09/2006	WO2006118127A1 Prophylactic/therapeutic agent for abnormalities of sugar/lipid metabolism
11/09/2006	WO2006118085A1 Agent for promoting hepatic cell replication and agent for improving insulin resistance
11/09/2006	WO2006117925A1 METHOD AND DEVICE FOR REGENERATING PANCREATIC β-CELLS
11/09/2006	WO2006117743A1 Substituted aromatic compounds as antidiabetic agents
11/09/2006	WO2006117696A2 Diastereoisomers of 4-hydroxyisoleucine and uses thereof
11/09/2006	WO2006117668A1 Fatty acid analogues, i.e. dha derivatives for uses as a medicament
11/09/2006	WO2006117664A1 New dha derivatives and their use as medicaments
11/09/2006	WO2006117221A1 Use of azapaullones for preventing and treating pancreatic autoimmune disorders
11/09/2006	WO2006117212A2 Use of gsk-3 inhibitors for preventing and treating pancreatic autoimmune disorders
11/09/2006	WO2006117076A1 Use of indolin-phenylsulfonamide derivatives
11/09/2006	WO2006117075A1 Use of indolin-phenylsulfonamide derivatives
11/09/2006	WO2006116815A1 Composition for the control of cholesterol levels
11/09/2006	WO2006116814A1 Composition and uses thereof
11/09/2006	WO2006099943A8 Amide-substituted 8-n-benzimidazoles, method for the production thereof, and use of the same as medicaments
11/09/2006	WO2006099941A8 Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments
11/09/2006	WO2006099940A8 Substituted, bicyclic 8-pyrrolidino-benzimidazoles, method for their production and their use as medicaments
11/09/2006	WO2006097337A9 11β-HYDROXYSTEROID DEHYDROGENASES
11/09/2006	WO2006041921A3 Preparation and uses of rhodanine derivatives
11/09/2006	WO2005120524A3 Nutritional formulations
11/09/2006	WO2005013988A8 2-`4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity
11/09/2006	US20060252839 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance
11/09/2006	US20060252814 Formulation comprising a betablocker and optionally a cholestrol-lowering agent
11/09/2006	US20060252810 e.g. 5-(4-Fluorophenyl)-4-(4-pyridinyl)imidazole-2-thio-3-propyl-N-phthalimide; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
11/09/2006	US20060252799 Benzo (F) insoindol derivatives and their use as EP4 receptor ligands
11/09/2006	US20060252797 Receptor regulator
11/09/2006	US20060252780 Fused pyrimidine derivatives
11/09/2006	US20060252767 Piperazine derivatives and their use as therapeutic agents
11/09/2006	US20060252730 Adenosine receptor antagonists and methods of making and using the same
11/09/2006	US20060252694 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
11/09/2006	US20060251713 Amino acid sequences capable of facilitating penetration across a biological barrier
11/09/2006	US20060251660 Antibodies to human IL-1beta
11/09/2006	US20060251651 Antagonist and agonist which bind to a strong binding site of chemokine receptor
11/09/2006	US20060251616 Migration of hematopoietic stem cells and progenitor cells to the liver
11/09/2006	DE102005020230A1 Verwendung von Indolin-Phenylsulfonamid-Derivaten Use of indoline derivatives phenylsulfonamide
11/09/2006	DE102005020229A1 Verwendung von Indolin-Phenylsulfonamid-Derivaten Use of indoline derivatives phenylsulfonamide
11/09/2006	CA2607777A1 Transdermal absorption enhancer

1 ... 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 ... 1298